Effects of VEGF-B on doxorubicin-induced cardiotoxicity

ABSTRACT: Doxorubicin is a widely used and effective anthracycline chemotherapy drug, which use is limited due to its cardiotoxic side effects. We show that gene therapy with AAV-VEGF-B can inhibit the doxorubicin-induced cardiac atrophy and whole body cachexia.

ORGANISM(S): Mus musculus

PROVIDER: GSE81448 | GEO | 2016/09/30

SECONDARY ACCESSION(S): PRJNA321605

REPOSITORIES: GEO